{"id":46465,"title":"[Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].","abstract":"A hepatitis B- és D-vírus-fert?zés id?ben történ? felfedezése és kezelése a beteg szempontjából a munkaképesség meg?rzését, az életmin?ség javulását, rákmegel?zést, valamint a betegségmentes várható élettartam meghosszabbodását, a beteg környezete és a társadalom szempontjából a továbbfert?zés veszélyének megállítását és a kezelés révén a kés?bbi súlyos májbetegségekb?l adódó jelent?s egészségügyi ráfordításigény-csökkenést jelent. Az irányelv célja a 2014. évre érvényes, a kezel?orvosok konszenzusán alapuló kezelési rend rögzítése. A magyar lakosság 0,5–0,7%-át sújtó hepatitis B-vírus-fert?zés kezelésének indikációja a vírusdiagnosztikán (benne vírusnukleinsav kimutatása), a májbetegség aktivitásának és stádiumának értékelésén (beleértve biokémiai, patológiai és/vagy nem invazív vizsgálómódszereket), valamint az ellenjavallatok kizárásán alapul. Az ajánlás hangsúlyozza a kivizsgálás során a gyors és részletes virológiai vizsgálatok jelent?ségét, a biopszia mellett a tranziens elasztográfia, illetve egyéb, validált, noninvazív tesztek alkalmazhatóságát csakúgy, mint a terápia vezetésében a vírusnukleinsav-titer követésének nélkülözhetetlenségét mind a mellékhatások elkerülése, mind a költséghatékonyság szempontjából. Az idült hepatitis B kezelésében egyaránt els? választás lehet a határozott – egyéves – id?tartamú pegilált interferon vagy a folyamatos entecavir- vagy tenofovirkezelés, amelyet a hepatitis B felszíni antigén szerokonverziója után még legalább 12 hónapig kell folytatni. Az adefovir leginkább kombinációban javasolható. Nem megfelel? els? választás a lamivudin, az ezt már szed? betegeket hatástalanság esetén másik szerre kell átállítani. Fontos az immunszuppresszív kezelésben és/vagy biológiai terápiában részesül? betegek megfelel? antivirális kezelése. Egyidej? hepatitis D esetén pegilált interferon kezelés szükséges. Orv. Hetil., 2014, 155(Szuppl. 2), 25–35.Diagnosis and treatment of hepatitis B and D virus infections mean that the patient is able to maintain working capacity, increase quality of life, prevent cancer, and prolong life expectancy, while the society benefits from eliminating the chances of further transmission of the viruses, and decreasing the overall costs of serious complications. The guideline delineates the treatment algorithms for 2014, which is agreed on a consensus meeting of specialists involved in the treatment of the above diseases. The prevalence of hepatitis B virus infection in the Hungarian general population is 0.5-0.7%. The indications of treatment is based upon viral examinations (including viral nucleic acid determination), determinations of disease activity and stage (including biochemical, pathologic, and/or non-invasive methods), and excluding contraindications. To avoid unnecessary side effects and for cost-effective approach the guideline emphasizes the importance of quick and detailed virologic evaluations, the applicability of transient elastography as an acceptable alternative of liver biopsy in this regard, as well as the relevance of appropriate consistent follow up schedule for viral response during therapy. The first choice of therapy in chronic hepatitis B infection can be pegylated interferon for 48 weeks or continuous entecavir or tenofovir therapy. The latter two must be continued for at least 12 months after hepatitis B surface antigen seroconversion. Adefovir dipivoxil is recommended mainly in combination therapy. Lamivudine is no longer a first choice; patients currently taking lamivudine must switch if response is inadequate. Appropriate treatment of patients taking immunosuppressive medications is highly recommended. Pegylated interferon based therapy is recommended for the treatment of concomitant hepatitis D infection.","date":"2014-03-17","categories":"Digestive System Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24631887","annotations":[{"name":"Lamivudine","weight":0.893958,"wikipedia_article":"http://en.wikipedia.org/wiki/Lamivudine"},{"name":"Hepatitis D","weight":0.889496,"wikipedia_article":"http://en.wikipedia.org/wiki/Hepatitis_D"},{"name":"Tenofovir","weight":0.877494,"wikipedia_article":"http://en.wikipedia.org/wiki/Tenofovir"},{"name":"Nucleic acid","weight":0.850764,"wikipedia_article":"http://en.wikipedia.org/wiki/Nucleic_acid"},{"name":"Hepatitis B","weight":0.840845,"wikipedia_article":"http://en.wikipedia.org/wiki/Hepatitis_B"},{"name":"Seroconversion","weight":0.826231,"wikipedia_article":"http://en.wikipedia.org/wiki/Seroconversion"},{"name":"Liver biopsy","weight":0.824329,"wikipedia_article":"http://en.wikipedia.org/wiki/Liver_biopsy"},{"name":"Biopsy","weight":0.816757,"wikipedia_article":"http://en.wikipedia.org/wiki/Biopsy"},{"name":"Interferon","weight":0.814657,"wikipedia_article":"http://en.wikipedia.org/wiki/Interferon"},{"name":"Cancer","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Cancer"},{"name":"Hepatitis B virus","weight":0.799199,"wikipedia_article":"http://en.wikipedia.org/wiki/Hepatitis_B_virus"},{"name":"Hepatitis","weight":0.797255,"wikipedia_article":"http://en.wikipedia.org/wiki/Hepatitis"},{"name":"Prevalence","weight":0.787846,"wikipedia_article":"http://en.wikipedia.org/wiki/Prevalence"},{"name":"Adverse effect","weight":0.774814,"wikipedia_article":"http://en.wikipedia.org/wiki/Adverse_effect"},{"name":"Immunosuppressive drug","weight":0.774554,"wikipedia_article":"http://en.wikipedia.org/wiki/Immunosuppressive_drug"},{"name":"Pathology","weight":0.767518,"wikipedia_article":"http://en.wikipedia.org/wiki/Pathology"},{"name":"Biochemistry","weight":0.75303,"wikipedia_article":"http://en.wikipedia.org/wiki/Biochemistry"},{"name":"Virology","weight":0.748573,"wikipedia_article":"http://en.wikipedia.org/wiki/Virology"},{"name":"Diagnosis","weight":0.742555,"wikipedia_article":"http://en.wikipedia.org/wiki/Diagnosis"},{"name":"Antigen","weight":0.734963,"wikipedia_article":"http://en.wikipedia.org/wiki/Antigen"},{"name":"Immunosuppression","weight":0.734616,"wikipedia_article":"http://en.wikipedia.org/wiki/Immunosuppression"},{"name":"Liver","weight":0.734616,"wikipedia_article":"http://en.wikipedia.org/wiki/Liver"},{"name":"Infection","weight":0.72904,"wikipedia_article":"http://en.wikipedia.org/wiki/Infection"},{"name":"Chronic (medicine)","weight":0.723286,"wikipedia_article":"http://en.wikipedia.org/wiki/Chronic_(medicine)"},{"name":"Virus","weight":0.709797,"wikipedia_article":"http://en.wikipedia.org/wiki/Virus"},{"name":"Disease","weight":0.701843,"wikipedia_article":"http://en.wikipedia.org/wiki/Disease"},{"name":"Pharmaceutical drug","weight":0.678276,"wikipedia_article":"http://en.wikipedia.org/wiki/Pharmaceutical_drug"},{"name":"PEGylation","weight":0.656132,"wikipedia_article":"http://en.wikipedia.org/wiki/PEGylation"},{"name":"Therapy","weight":0.654651,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Viral disease","weight":0.654651,"wikipedia_article":"http://en.wikipedia.org/wiki/Viral_disease"},{"name":"Adefovir","weight":0.621885,"wikipedia_article":"http://en.wikipedia.org/wiki/Adefovir"},{"name":"Quality of life","weight":0.619099,"wikipedia_article":"http://en.wikipedia.org/wiki/Quality_of_life"},{"name":"Orders of magnitude (mass)","weight":0.561886,"wikipedia_article":"http://en.wikipedia.org/wiki/Orders_of_magnitude_(mass)"},{"name":"Life expectancy","weight":0.523264,"wikipedia_article":"http://en.wikipedia.org/wiki/Life_expectancy"},{"name":"Transmission (medicine)","weight":0.518514,"wikipedia_article":"http://en.wikipedia.org/wiki/Transmission_(medicine)"},{"name":"Combination therapy","weight":0.513366,"wikipedia_article":"http://en.wikipedia.org/wiki/Combination_therapy"},{"name":"Contraindication","weight":0.449525,"wikipedia_article":"http://en.wikipedia.org/wiki/Contraindication"},{"name":"Patient","weight":0.418173,"wikipedia_article":"http://en.wikipedia.org/wiki/Patient"},{"name":"Acid","weight":0.353195,"wikipedia_article":"http://en.wikipedia.org/wiki/Acid"},{"name":"Hungary","weight":0.223991,"wikipedia_article":"http://en.wikipedia.org/wiki/Hungary"},{"name":"Invasiveness of surgical procedures","weight":0.21571,"wikipedia_article":"http://en.wikipedia.org/wiki/Invasiveness_of_surgical_procedures"},{"name":"Complication (medicine)","weight":0.201782,"wikipedia_article":"http://en.wikipedia.org/wiki/Complication_(medicine)"},{"name":"Entecavir","weight":0.142982,"wikipedia_article":"http://en.wikipedia.org/wiki/Entecavir"},{"name":"Scientific consensus","weight":0.133922,"wikipedia_article":"http://en.wikipedia.org/wiki/Scientific_consensus"},{"name":"Physical examination","weight":0.0840959,"wikipedia_article":"http://en.wikipedia.org/wiki/Physical_examination"},{"name":"Algorithm","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/Algorithm"},{"name":"Cancer staging","weight":0.0365852,"wikipedia_article":"http://en.wikipedia.org/wiki/Cancer_staging"},{"name":"Alternative medicine","weight":0.0337327,"wikipedia_article":"http://en.wikipedia.org/wiki/Alternative_medicine"},{"name":"Medical guideline","weight":0.0185939,"wikipedia_article":"http://en.wikipedia.org/wiki/Medical_guideline"},{"name":"Mean","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Mean"},{"name":"Mind","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Mind"},{"name":"Democratic Party (United States)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Democratic_Party_(United_States)"},{"name":"Mentha","weight":0.0152478,"wikipedia_article":"http://en.wikipedia.org/wiki/Mentha"},{"name":"Population","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Population"},{"name":"Tonne","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Tonne"},{"name":"Society","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Society"}]}
